Concepedia

Publication | Open Access

Safety and efficacy of odronextamab in patients with relapsed or refractory follicular lymphoma

DOIFull Paper Access

60

Citations

19

References

2024

Year

Tae Min Kim, Michał Taszner, Silvana Novelli, Seok‐Goo Cho, José C. Villasboas, Michele Merli, Ana Jiménez Ubieto, Benoît Tessoulin, Li Mei Poon, David Tucker,
Annals of Oncology

Abstract

Odronextamab achieved high complete response rates with generally manageable safety in patients with heavily pretreated R/R follicular lymphoma.

References

YearCitations

Page 1